|
Jul 15
|
Lilly’s Zepbound Faces a Potential Weight-Loss Rival. It’s Made by a Chinese Biotech.
|
|
Jul 15
|
Astrazeneca (AZN) is a Top-Ranked Growth Stock: Should You Buy?
|
|
Jul 15
|
Tempus AI Raises 2025 Financial Outlook: What's Backing It?
|
|
Jul 15
|
AstraZeneca PLC (AZN) Secures EU Approval for Imfinzi
|
|
Jul 15
|
AstraZeneca Meets All Key Goals in Phase III Hypertension Study
|
|
Jul 15
|
Cancer drugmaker LaNova to sell to China’s Sino Biopharm
|
|
Jul 15
|
AstraZeneca’s Phase III trial of baxdrostat shows mean SBP reduction
|
|
Jul 15
|
Chronic Rhinosinusitis with Nasal Polyps Market Analysis and Forecast Report 2025-2035, Featuring AstraZeneca, Amgen, GlaxoSmithKline, Keymed Biosciences, Biohaven Pharmaceuticals, Sanofi, and More
|
|
Jul 15
|
AWS plans $100M Generative AI Innovation Center expansion
|
|
Jul 14
|
AstraZeneca (LSE:AZN) Unveils Promising Phase III Results For Baxdrostat In Hypertension Trial
|
|
Jul 14
|
European Equities Close Mixed in Monday Trading; EU Signals Readiness to Retaliate Against US Tariffs
|
|
Jul 14
|
Here's Why Astrazeneca (AZN) is a Strong Value Stock
|
|
Jul 14
|
HER2+ Gastric Cancer Market Analysis and Forecast Report 2025-2035: AstraZeneca, Merck, and Roche Lead Innovation in HER2+ Gastric Cancer Therapies
|
|
Jul 14
|
Baxdrostat met the primary and all secondary endpoints in BaxHTN Phase III trial in patients with uncontrolled or treatment resistant hypertension
|
|
Jul 14
|
Trending tickers: Lionsgate, Nio, Boeing, AstraZeneca and Fresnillo
|
|
Jul 14
|
FTSE 100 higher and US stocks mixed ahead of US inflation data
|
|
Jul 14
|
European shares end lower as Trump's tariff threats keep markets on edge
|
|
Jul 13
|
China Biotech’s Stunning Advance Is Changing the World’s Drug Pipeline
|
|
Jul 13
|
Danaher (DHR) Teams Up to Advance Precision Medicine Diagnostics
|
|
Jul 12
|
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
|